Steve Brozak

Last updated
Steve Brozak
Steve Brozak Photo.jpg
Born1961
New York City, New York, U.S.
Alma mater Columbia University School of General Studies
Columbia Business School
Drew University
Occupation(s)President of WBB Securities, LLC;
Financial Analyst;
Investment Banker
Military career
AllegianceFlag of the United States (Pantone).svg United States
Service/branchFlag of the United States Marine Corps.svg  United States Marine Corps
Years of service
  • 1982-1985 (Active)
  • 1986-2001 (Reserve)
  • 2001-2003 (Active)
Rank US-O5 insignia.svg Lieutenant Colonel

Steve Brozak (born 1961) is the Managing Partner and President of WBB Securities, LLC, a Democratic congressional candidate in the 2004 American election cycle, and was the Chairman and CEO of StormBio, Inc. Brozak was named a 2013 StarMine "Top Stock Picker" among Pharmaceutical Analysts by the Thomson Reuters Awards for Excellence, and was recognized by The Wall Street Journal as "Best on the Street" among Medical Equipment and Supplies financial analysts. [1] Brozak is a retired Lieutenant Colonel in the United States Marine Corps. He served a three-year appointment to the Secretary of Navy's Navy and Marine Corps Retiree Council. He also is a Fellow of Foreign Policy Association.

Contents

Education

Brozak received his BA from Columbia University (1982), MBA from Columbia Business School (1994) and Doctor of Medical Humanities (DMH) from Drew University (2016). [2]

Career

Brozak is the President and Co-founder of WBB Securities, LLC, an independent broker dealer, investment bank and sell-side research firm. WBB Securities focuses on healthcare, biotechnology, pharmaceutical and medical device research and banking. [3] WBB Securities and its analysts are ranked consistently as top performers in research accuracy. In September 2016, WBB Securities added an asset management arm to the firm, which subsequently launched a long/short equity healthcare fund named WBB Life Sciences l/s. [4]

As president of WBB Securities, Brozak is responsible for the research and investment banking division. He raises funds for public offerings in various healthcare sectors. He has been ranked one of the top analysts of all First Call submitting analysts in all healthcare sectors over the past five years by the StarMine ranking system. In 2010, he was named one of the Top Analysts in the Healthcare Sector for the United States by the Financial Times and StarMine. [5] As being named 2013 StarMine "top stock picker" among Pharmaceutical Analysts, Brozak has achieved top-ranking recognition in all healthcare fields including Biotechnology, Medical Devices, and Pharmaceuticals over the last five years by the Thomson Reuters Awards for Excellence and The Wall Street Journal Best on the Street Survey. [6] He is a Fellow of the Foreign Policy Association. [7]

Brozak has specific expertise and interest in human stem cell therapies, biothreat countermeasures, bacterium, and viruses such as highly pathogenic influenza, Marburg, and Ebola. [8]

He is a contributor to Forbes , Businessweek , STAT, CNN, and ABCNews.com while regularly authoring articles in peer-reviewed and news publications. Among articles are:

Brozak is frequently interviewed and quoted by such media sources as the Associated Press, ABC, Barron's , Bloomberg, CNN, Financial Times , Forbes , Dow Jones, Reuters, USA Today , TheStreet.com, and The Wall Street Journal . He is featured in the British Medical Journal raising awareness among the cleanliness of endoscopic procedures within the United States. [9] He is co-author of three commentaries about the failure of the Fukushima Daichi nuclear power plants and the potential impact on the world, published by ABCNews.com. They include: Fukushima Joins Titanic, Katrina as a Single Word for Disaster, March 16, 2011, [10] Fukushima: A Nuclear Threat to Japan, the U.S. and the World, April 6, 2011 [11] and Fukushima and Nuclear Power: Playing with Fire, April 25, 2011. [12] He also is the author of twelve analytical reports about the threat of pandemic influenza, has written guest editorials and been asked to speak about several issues, including the challenges facing large pharmaceutical companies, the need to restructure the U.S. Food and Drug Administration, and difficulties facing the U.S. healthcare system. [13] [14]

Brozak participated in the production of two films- as an Associate Producer of Money for Nothing: Inside the Federal Reserve (2013) [15] and as Executive Producer of American Veteran (2017). [16]

Brozak was Chairman and CEO of StormBio, Inc, a development stage biotechnology company focused on the attenuation of Cytokine Storm, specifically in influenza. StormBio was developing therapeutics to minimize the mortality and morbidity resulting from Highly Pathogenic Influenza infections, such as H5N1 and H1N1 influenza strains. [17]

StormBio's approach was to modulate runaway inflammation. Many of the deaths and much of the permanent damage from influenza is caused by a runaway inflammatory process called cytokine storm. It was anticipated that StormBio's therapeutics also could be used to treat a variety of other inflammatory conditions. StormBio was affiliated with leading scientists in the field of inflammation and had in-licensed intellectual property and novel therapeutics directed at treating people in the event of an influenza pandemic. [18]

Political life

Steve Brozak with Chairman & CEO, Salvatore Sodano opening the American Stock Exchange on August 2, 2004 AMEX Opening Aug-2-2004.jpg
Steve Brozak with Chairman & CEO, Salvatore Sodano opening the American Stock Exchange on August 2, 2004
LtCol Steve Brozak USMCR speaking at the state capitol in Trenton at the NJ Governor's SOS Ceremony on May 14, 2003 At Trenton for ESGR NJ Governor Ceremony.jpg
LtCol Steve Brozak USMCR speaking at the state capitol in Trenton at the NJ Governor's SOS Ceremony on May 14, 2003

Campaigning for Congress during the 2004 election, Brozak kicked off his campaign with a front-page feature story, "A Marine Jumps Party Lines to Join Democrats in Trenches", in The Wall Street Journal, where he gave early warning of the nearly insurmountable challenges faced by the shortage of U.S. troops in Iraq and the need for a modified strategy to subdue insurgency and create a secure nation in Iraq. [19] His campaign focused on the lack of planning for the Iraq war, the strain it placed on our military, and the severe economic repercussions that would ensue—specifically the rise in energy prices. He also stressed the need for unfettered research in stem cells and the need for a fair trade policy with other countries. Brozak was featured in an article in the magazine Salon, which described his campaign as "a referendum on Bush's military folly." [20]

During his Congressional campaign, Brozak was invited to speak during prime time at the 2004 Democratic National Convention, where he criticized the Bush administration for lack of planning prior to the war in Iraq. [21] He was later criticized by bloggers in the Internet publication, The Weekly Standard for his strong position against administration partisanship in political appointments at the Pentagon. [22] Brozak was defeated by incumbent Mike Ferguson (Republican) for New Jersey's 7th Congressional District.

Military career

Brozak is a retired Lieutenant Colonel in the United States Marine Corps, having served in Europe, the Middle East, Asia, and the Caribbean. He has been attached to units within the United Nations, specifically as a Foreign area officer at the U.S. Mission to the United Nations, and as a Public Information Officer in the United Nations Mission in Haiti (UNMIH). Brozak was also attached to units within NATO (North Atlantic Treaty Organization) and has worked with the Inter-American Defense Board. [23]

Brozak resumed active duty service in the Marine Corps immediately after the September 11 attacks in 2001 as Officer in Charge of Mobilization Training Unit NY- 17 in New York City. He later served as part of Operation Enduring Freedom, leading a team to the Middle East to evaluate National Guard and Reserve mobilization. Upon returning from Iraq, his team wrote a report that criticized the lack of troop strength and drain on the reserves caused by the Iraq/Afghanistan deployments. [24] His subsequent active duty assignment before retiring was Chief Spokesperson for OSD's National Committee for the Employer support of the Guard and Reserve [25] in Washington D.C. [26] Brozak participated as a Marine Corps officer representing the Department of Navy and Marine Corps retirees on the SECNAV Retiree Council. Brozak was twice awarded the Navy/Marine Corps Meritorious Service Medal, his last one for his efforts in Washington. [27]

Personal life

Born in 1961, Brozak is married and has two children. Brozak has been a resident of Westfield, New Jersey. [28]

Published works

Related Research Articles

<span class="mw-page-title-main">Bioterrorism</span> Terrorism involving biological agents

Bioterrorism is terrorism involving the intentional release or dissemination of biological agents. These agents include bacteria, viruses, insects, fungi, and/or their toxins, and may be in a naturally occurring or a human-modified form, in much the same way as in biological warfare. Further, modern agribusiness is vulnerable to anti-agricultural attacks by terrorists, and such attacks can seriously damage economy as well as consumer confidence. The latter destructive activity is called agrobioterrorism and is a subtype of agro-terrorism.

Biodefense refers to measures to counter biological threats, reduce biological risks, and prepare for, respond to, and recover from bioincidents, whether naturally occurring, accidental, or deliberate in origin and whether impacting human, animal, plant, or environmental health. Biodefense measures often aim to improve biosecurity or biosafety. Biodefense is frequently discussed in the context of biological warfare or bioterrorism, and is generally considered a military or emergency response term.

<span class="mw-page-title-main">United States Department of Health and Human Services</span> Department of the US federal government

The United States Department of Health and Human Services (HHS) is a cabinet-level executive branch department of the U.S. federal government created to protect the health of the U.S. people and providing essential human services. Its motto is "Improving the health, safety, and well-being of America". Before the separate federal Department of Education was created in 1979, it was called the Department of Health, Education, and Welfare (HEW).

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in Forbes Global 2000 was 89.

<span class="mw-page-title-main">Matthew Bogdanos</span> American lawyer

Colonel Matthew Bogdanos is an Assistant District Attorney in Manhattan, author, boxer, and a retired colonel in the United States Marine Corps. Following the September 11, 2001 attacks, Bogdanos deployed to Afghanistan where he was awarded a Bronze Star for actions against Al-Qaeda and the Taliban. In 2003, while on active duty in the Marine Corps, he led an investigation into the looting of Iraq's National Museum, and was subsequently awarded the National Humanities Medal for his efforts. Returning to the District Attorney’s Office in 2010, he created and still heads the Antiquities Trafficking Unit, “the only one of its kind in the world.” He had previously gained national attention for the prosecution of Sean Combs, who was acquitted of weapons and bribery charges in a 2001 trial stemming from a 1999 nightclub shootout.

The Johns Hopkins Center for Health Security is an independent, nonprofit organization of the Johns Hopkins Bloomberg School of Public Health. The center works to protect people's health from epidemics and pandemics and ensures that communities are resilient to major challenges. The center is also concerned with biological weapons and the biosecurity implications of emerging biotechnology.

John J. Nance is an American pilot, attorney, aviation and healthcare safety analyst, and author.

<span class="mw-page-title-main">Project Bioshield Act</span> US law

The Project Bioshield Act was an act passed by the United States Congress in 2004 calling for $5 billion for purchasing vaccines that would be used in the event of a bioterrorist attack. This was a ten-year program to acquire medical countermeasures to biological, chemical, radiological, and nuclear agents for civilian use. A key element of the Act was to allow stockpiling and distribution of vaccines which had not been tested for safety or efficacy in humans, due to ethical concerns. Efficacy of such agents cannot be directly tested in humans without also exposing humans to the chemical, biological, or radioactive threat being treated, so testing follows the FDA Animal Rule for pivotal animal efficacy.

<span class="mw-page-title-main">Patrick Soon-Shiong</span> South African billionaire physician, CEO & philanthropist (b. 1952)

Patrick Soon-Shiong is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.

<span class="mw-page-title-main">Biomedical Advanced Research and Development Authority</span> Government organization in Washington D.C., United States

The Biomedical Advanced Research and Development Authority (BARDA) is a U.S. Department of Health and Human Services (HHS) office responsible for the procurement and development of medical countermeasures, principally against bioterrorism, including chemical, biological, radiological and nuclear (CBRN) threats, as well as pandemic influenza and emerging diseases. BARDA was established in 2006 through the Pandemic and All-Hazards Preparedness Act (PAHPA) and reports to the Office of the Assistant Secretary for Preparedness and Response (ASPR). The office manages Project BioShield, which funds the research, development and stockpiling of vaccines and treatments that the government could use during public health emergencies such as chemical, biological, radiological or nuclear (CBRN) attacks.

Shionogi & Company, Limited is a Japanese pharmaceutical company best known for developing Crestor. Medical supply and brand name also uses katakana (シオノギ).

Lindsay A. Rosenwald is an American doctor, biotechnology and life sciences industry investor. He is the co-founder of the healthcare private equity firm Opus Point Partners. Rosenwald has created and sold several biotechnological companies. In 2013 he established Fortress Biotech.

<span class="mw-page-title-main">Joseph Jimenez</span>

Joseph Jimenez is the former CEO of the Swiss pharmaceutical company Novartis.

Arie S. Belldegrun, FACS, is an Israeli-American urologic oncologist, billionaire businessman and investor.

David Grainger is a partner at medicxi, a European life sciences-oriented venture capital firm and chief executive officer of Methuselah Health Ltd., a drug development company doing proteomics research in the longevity space.

BioMotiv is an accelerator company associated with The Harrington Project, an initiative centered at University Hospitals of Cleveland. Therapeutic opportunities were identified through relationships with The Harrington Discovery Institute, university and research institutions, disease foundations, and industry sources. Once opportunities are identified, BioMotiv oversees the development, funding, active management, and partnering of the therapeutic products.

<span class="mw-page-title-main">Biotechnology Innovation Organization</span> Biotechnology advocacy association

The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry. It was founded in 1993 as the Biotechnology Industry Organization from a merger of the Industrial Biotechnology Association (IBA) and the Association of Biotechnology Companies (ABC), and changed its name to the Biotechnology Innovation Organization on January 4, 2016. Biotechnology Innovation Organization serves more than 1,100 biotechnology firms, research schools, state biotechnology centers and related associations in the United States and in more than 30 other countries.

<span class="mw-page-title-main">Alliance for Biosecurity</span>

The Alliance for Biosecurity is a consortium of companies that develop products to respond to national security threats, including bioterrorism pathogens and emerging infectious diseases. It is headquartered in Washington DC.

<span class="mw-page-title-main">Pete Gaynor</span> American government official (born 1958)

Peter Thomas Gaynor is an American Certified Emergency Manager who served briefly as acting Secretary of Homeland Security under President Trump. Gaynor previously served as administrator of the Federal Emergency Management Agency (FEMA). He was appointed as Acting Administrator by President Donald Trump on March 8, 2019, and became Administrator on January 16, 2020.

Planning and preparing for pandemics has happened in countries and international organizations. The World Health Organization writes recommendations and guidelines, though there is no sustained mechanism to review countries' preparedness for epidemics and their rapid response abilities. National action depends on national governments. In 2005–2006, before the 2009 swine flu pandemic and during the decade following it, the governments in the United States, France, UK, and others managed strategic health equipment stocks, but they often reduced stocks after the 2009 pandemic in order to reduce costs.

References

  1. ↑ "Best on the Street Stock Analysts: Medical Equipment & Supplies". WSJ.com. 2011-05-09. Retrieved 2012-11-24.
  2. ↑ "Steve Brozak | Doctor of Medical Humanities | Research".
  3. ↑ "WBB Securities, LLC". Wbbsec.com. Retrieved 2012-11-24.
  4. ↑ "Healthcare pro and ex-JP Morgan exec launch healthcare fund". 2017-05-12.
  5. ↑ The Financial Times and StarMine Present the Top Analysts of 2010 for the United States at the Wayback Machine (archived June 3, 2010)
  6. ↑ "Financial Times and Thomson Reuters name Steve Brozak as a 2013 StarMine | WBB Securities, LLC". 22 August 2013.
  7. ↑ "Foreign Policy Association".
  8. ↑ Melissa Davis (2007-06-26). "Three Stem-Cell Stocks Ripe With Potential". TheStreet. Archived from the original on 2012-09-13. Retrieved 2012-11-24.
  9. ↑ "A 21st century nosocomial issue with endoscopes" (PDF). bmj.com. BMJ. 19 March 2014. doi:10.1136/bmj.g2047 . Retrieved Aug 13, 2024.
  10. ↑ Opinionby Stephen Brozak And Henry Bassman (2011-03-16). "Japan's Fukushima: How Can We Prepare for Disaster? - ABC News". Abcnews.go.com. Retrieved 2012-11-24.
  11. ↑ Opinionby Stephen Brozak And Henry Bassman (2011-04-06). "Fukushima Leak: A Threat to Japan, the U.S. and the World - ABC News". Abcnews.go.com. Retrieved 2012-11-24.
  12. ↑ Opinionby Stephen Brozak And Henry Bassman (2011-04-25). "Fukushima and Nuclear Power: Energy Lessons From Japan's Tragedy - ABC News". Abcnews.go.com. Retrieved 2012-11-24.
  13. ↑ "Attack Of The Zombie Biotechs". Forbes.com. Retrieved 2012-11-24.
  14. ↑ "Why Your Health Care Is in Jeopardy - ABC News". Abcnews.go.com. 2009-02-19. Retrieved 2012-11-24.
  15. ↑ Money for Nothing: Inside the Federal Reserve (2013) , retrieved 2017-11-07
  16. ↑ "American Veteran". Heartland Film. Retrieved 2017-11-07.
  17. ↑ "StormBio: Taming Cytokine Storm". Archived from the original on 18 July 2013. Retrieved 18 January 2013.
  18. ↑ "Cytokine Storm: A Deadly Effect of Flu". Storm Bio: Taming Cytokine Storm. Archived from the original on 7 December 2013. Retrieved 18 January 2013.
  19. ↑ "A Marine Jumps Party Lines to Join Democrats in Trenches". WSJ.com. 2004-04-21. Retrieved 2012-11-24.
  20. ↑ Goldberg, Michelle (2004-09-30). "Marine declares war on Bush - Salon.com". Dir.salon.com. Archived from the original on 2011-06-07. Retrieved 2012-11-24.
  21. ↑ "Ret. Lt. Colonel Steve Brozak's Speech before the Democratic National Convention". PRNewswire. July 28, 2004. Archived from the original on 2012-10-04. Retrieved 2019-08-22.
  22. ↑ Hernandez, Raymond (2004-08-08). "Ex-Marine Takes Aim At a Republican". The New York Times. Retrieved 2012-11-24.
  23. ↑ "Stephen G. Brozak" (PDF). Rotary Club of New York. Retrieved 18 January 2013.
  24. ↑ Liu, Petersi. "ESGR Reps Check on Guard and Reserve in Iraq". Defend America. Archived from the original on 5 January 2014. Retrieved 18 January 2013.
  25. ↑ "Employer Support of the Guard and Reserve > Home". Esgr.net. Retrieved 2012-11-24.
  26. ↑ "Candidate - Stephen G. Brozak". Our Campaigns. 2004-05-01. Retrieved 2012-11-24.
  27. ↑ "Seventh Congressional District" (PDF). The Westfield Leader. Watchung Communications, Inc. Retrieved 18 January 2013.
  28. ↑ Hernandez, Raymond. "Ex-Marine Takes Aim At a Republican", The New York Times , August 8, 2004. Accessed October 26, 2015. " NOT long ago, Steve Brozak was a little-known Marine officer who had returned home to Westfield from a tour of duty in Iraq, disillusioned with President Bush's handling of the war there."
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.